|May. 10, 2018|
Jakarta, May 10, 2018 - Byung Ki Kim, managing director of Direx
Korea, began a road show this week to
promote Direx' thermal therapy solution for prostatic conditions - The unique
bipolar RF Tempro system.
Tempro is being introduced, in collaboration with Nan-Medika -
Direx' distributing partner in Indonesia for Tempro, to leading medical
centers in Jakarta. The tour's goal is to present the uniqueness, benefits and
advantages of Tempro. The curriculum will focus on the most important
"best practices" for private clinics, physicians and hospitals.
Direx' Tempro administers controlled heat to the
prostatic tissue using a unique bipolar RF energy source. The product provides
a personalized treatment for each patient according to his Prostatic Urethral
Length (PUL). Utilizing a flexible catheter, the treatment does not require rectal
Tempro therapy is clinically proven for both BPH and Prostatitis.
It's an in-office, simple, single-session procedure that is safe with minimal side
effects. There is real time temperature monitoring through the entire
"I am extremely excited to introduce Tempro in Indonesia", Mr.
Kim stated, "Roadshows are always a challenge, but also satisfying. I am happy
to share our vast experience with Tempro from almost 50 medical centers in
Korea". Mr. Munadi Herlambang, CEO
of Nan-Medika added: "Tempro provides a minimal invasive solution to BPH
and Prostatitis. It offers an intuitive, simple to operate system and the
initial response from our local urologists has been fantastic".
DirexGroup was established over 35
years ago and has continuously extended its presence in countries and markets
worldwide. DirexGroup has put its emphasis on the field of urology with a line
of shockwave lithotripsy and therapy systems, as well as lasers and thermal
therapy technologies for urology. Direx most recently is leading the field with
its unique shockwave therapy solutions for treatment of erectile dysfunction
and chronic wounds.